Taiwan FDA registration 7f10256509ad4e663f115bbfc7c0fe9e
Trinity Biotech Angiotensin Converting Enzyme (ACE) Reagent
TW: 崔尼蒂生技血管緊縮素轉換酶試劑
Taiwan·Risk Class 2·MD·TRINITY BIOTECH PLC·Registered Oct 04, 2013 – Oct 04, 2018CancelledRegistration details
- Analysis ID
- 7f10256509ad4e663f115bbfc7c0fe9e
- License Form
- Ministry of Health Medical Device Import No. 025526
- Customs Code
- DHA05602552602
Company information
- Manufacturer
- TRINITY BIOTECH PLC
- Manufacturer Country
- Ireland
- Authorized Representative
- BioChain Co., Ltd.
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1090 Angioconstrictin conversion test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 04, 2013
- Expiry Date
- Oct 04, 2018
- Cancellation Date
- Jun 16, 2022
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期未申請展延
About this record
Access comprehensive regulatory information for Trinity Biotech Angiotensin Converting Enzyme (ACE) Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7f10256509ad4e663f115bbfc7c0fe9e and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices